Eye growth transformation: uveal melanoma

References

• Schmidt-Pokrzyniak A, Jockel K, Bornfeld N, Sauerwein W, Stang A. Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma. Ophthalmology116, 340–348 (2009).
   PubMedGoogle Scholar
• Isager P, Osterlind A, Engholm G et al. Uveal and conjunctival malignant melanoma in Denmark, 1993–1997: incidence and validation study. Ophthalmic Epidemiol.12(4), 223–232 (2005).
   PubMed Web of Science ®Google Scholar
• Hurst E, Harbour J, Cornelius L. Ocular melanoma. A review and the relationship to cutaneous melanoma. Arch. Dermatol.139(8), 1067–1073 (2003).
   PubMed Web of Science ®Google Scholar
• Augsburger J, Correa Z, Trichopoulos N, Shaikh A. Size overlap between melanocytic choroidal nevi and choroidal malignant melanomas. Invest. Ophthalmol. Vis. Sci.49(7), 2823–2828 (2008).
   PubMedGoogle Scholar
• Landreville S, Agapova O, Harbour W. Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol.4(5), 629–636 (2008).
   PubMed Web of Science ®Google Scholar
• Stang A, Parkin D, Ferlay J, Jockel K. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int. J. Cancer114, 114–123 (2005).
   PubMed Web of Science ®Google Scholar
• Smith J, Padnick-Silver L, Newlin A, Rhodes K, Runstein W. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi. Ophthalmology114, 774–779 (2007).
   PubMed Web of Science ®Google Scholar
• Schmidt-Pokrzyniak A, Jockel K, Bornfeld N, Stang A. Case–control study on uveal melanoma (RIFA): rationale and design. BMC Ophthalmol.4, 11 (2004).
   PubMedGoogle Scholar
• Weis E, Shah C, Lajous M, Shields J, Shields C. Host susceptibility factors are associated with uveal melanoma: a meta-analysis. Arch. Ophthalmol.124(1), 54–60 (2006).
   PubMedGoogle Scholar
• Shah C, Weis E, Lajous M, Shields J, Shields C. Intermittent and chronic light exposure and uveal melanoma. Ophthalmology112, 1599–1607 (2005).
   PubMed Web of Science ®Google Scholar
• Shields C, Furata M, Berman E et al. Choroidal nevus transformation into melanoma. Arch. Ophthalmol.127(8), 981–987 (2009).
   PubMedGoogle Scholar
• Singh A, Kalyani P, Topham A. Estimating the risk of malignant transformation of a choroidal nevus. Ophthalmology112, 1784–1789 (2005).
   PubMed Web of Science ®Google Scholar
• Triozzi P, Eng C, Singh A. Targeted therapy for uveal melanoma. Cancer Treat. Rev.34, 247–258 (2008).
   PubMedGoogle Scholar
• Kodjikian L, Grange J, Baldo S, Baillif S, Garweg J, Rivoire M. Prognostic factors of liver metastases from uveal melanoma. Graefes Arch. Clin. Exp. Ophthalmol.243, 985–993 (2005).
   PubMedGoogle Scholar
• Shields C. The hunt for the secrets of uveal melanoma. Clin. Exp. Ophthalmol.36, 277–280 (2008).
   PubMedGoogle Scholar
• Damato B, Duke C, Coupland S et al. Cytogenetics of uveal melanoma. Ophthalmology114, 1925–1931 (2007).
   PubMed Web of Science ®Google Scholar
• Seddon J, Young T. Epidemiology of uveal melanoma. In: Retina (Volume 1). Elsevier Inc., Amsterdam, The Netherlands, 691–697 (2006).
   Google Scholar
• Harbour J, Brantley M Jr, Hollingsworth H, Gordon M. Association between choroidal pigmentation and posterior uveal melanoma in a white population. Br. J. Ophthalmol.88, 39–43 (2004).
   PubMed Web of Science ®Google Scholar
• Hoai T, Zografas L. Primary choroidal melanoma in phakomatosis pigmentovascularis IIa. Ophthalmology112, 1232–1235 (2005).
   PubMedGoogle Scholar
• Richtig E, Langmann G, Mullner K, Smolle J. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi. Ophthalmologica218, 111–114 (2004).
   PubMedGoogle Scholar
• Weis E, Shah C, Lajous M, Shields J, Shields C. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis. Ophthalmology116, 536–543 (2009).
   PubMed Web of Science ®Google Scholar
• Fernandes BF, Marshall JC, Burnier MN Jr. Blue light exposure and uveal melanoma. Ophthalmology113(6), 1062.el (2006)
   Google Scholar
• Manning WS Jr, Greenlee PG, Norton JN. Ocular melanoma in a Long Evans rat. Contemp. Top. Lab. Anim. Sci.43(1), 44–46 (2004).
   PubMedGoogle Scholar
• Di Cesare S, Maloney S, Fernandes B et al. The effect of blue light exposure in an ocular melanoma animal model. J. Exp. Clin. Res.28, 48 (2009).
   PubMedGoogle Scholar
• Fernandes BF, Krema H, Fulda E, Pavlin C, McGowan C, Simpson C. Management of iris melanoma with iodine 125 plaque radiotherapy. Am. J. Ophthalmol.149(1), 70–76 (2009).
   PubMedGoogle Scholar
• Rouse D, Rouse L. Conversion of a benign choroidal nevus into a malignant melanoma. Optometry75(6), 366 (2004).
   Google Scholar
• Bass S, Sherman J. Choroidal nevus transformation to malignant melanoma. Clin. Eye Vis. Care10, 41–43 (1998).
   Google Scholar
• Shields C, Furuta M, Mashayekhi A et al. Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes. Ophthalmology115, 546–552 (2008).
   PubMed Web of Science ®Google Scholar
• Li H, Shields C, Mashayekhi A et al. Giant choroidal nevus. Ophthalmology117, 324–333 (2010).
   PubMedGoogle Scholar
• Eichhorn-Mulligan K, Kim I. Nevus or melanoma?. How to differentiate. Rev. Ophthalmol.15(4), (2008).
   Google Scholar
• Lavinsky D, Belfort R, Navajas E et al. Fundus and autofluorescence of choroidal nevus and melanoma. Br. J. Ophthalmol.91, 1299–1302 (2007).
   PubMed Web of Science ®Google Scholar
• Khan J, Damato B. Accuracy of choroidal melanoma diagnosis by general ophthalmologists: a prospective study. Eye21, 595–597 (2007).
   PubMed Web of Science ®Google Scholar
• Kaiserman I, Kaiserman N, Pe’er J. Long term ultrasonic follow up of choroidal nevi and their transformation to melanomas. Br. J. Ophthalmol.90, 994–998 (2006).
   PubMedGoogle Scholar
• Shields C, Furata M, Thangappan A et al. Metastasis of uveal melanoma millimeter by millimeter in 8033 consecutive eyes. Arch. Ophthalmol.127(8), 989–998 (2009).
   PubMedGoogle Scholar
• Singh A, Terman S, Sculley L. Estimating choroidal melanoma volume. Ophthalmology114, 1212–1214 (2007).
   PubMedGoogle Scholar
• Gunduz K, Pulido J, Bakri S, Amselem L, Petit-Fond E, Link T. Fundus autofluorescence of choroidal melanocytic lesions and the effect of treatment. Trans. Am. Ophthalmol. Soc.105, 172–178 (2007).
   PubMedGoogle Scholar
• Coupland S, Campbell I, Damato B. Routes of extra ocular extension of uveal melanoma. Risk factors and influence on survival probability. Ophthalmology115, 1778–1785 (2008).
   PubMed Web of Science ®Google Scholar
• Marshall JC, Fernandes B, Di Cesare S et al. The use of cyclooxygenase-2 inhibitor (Nepafenac) in a ocular and metastatic animal model of uveal melanoma. Carcinogenesis28(9), 2053–2058 (2007).
   PubMed Web of Science ®Google Scholar
• Bakalian S, Marshall JC, Logan P et al. Molecular pathways mediating liver metastasis in patients with uveal melanoma. Clin. Cancer Res.14(4), 951–956 (2008).
   PubMed Web of Science ®Google Scholar
• Kujala E, Kivela T. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma. Evaluation of the 6th edition and future directions. Ophthalmology112, 1135–1144 (2005).
   PubMed Web of Science ®Google Scholar
• Rundle P, Singh A, Rennie I. Proton beam therapy for iris melanoma: a review of 15 cases. Eye21, 79–82 (2007).
   PubMedGoogle Scholar
• Lumbroso-Le Rouic L, Delacroix S, Dendale R et al. Proton beam therapy for iris melanomas. Eye20, 1300–1305 (2006).
   PubMedGoogle Scholar
• Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S. Ruthenium brachytherapy for uveal melanoma, 1979–2003. Ophthalmology112, 834–840 (2005).
   PubMed Web of Science ®Google Scholar
• Boldt H, Melia BM, Liu J, Reynolds S. I-125 brachytherapy for choroidal melanoma. Photographic and angiographic abnormalities: the collaborative ocular melanoma study: COMS report No. 30. Ophthalmology116, 106–115 (2009).
   PubMed Web of Science ®Google Scholar
• Finger P, Chin K, Duvall G. Palladium-103 ophthalmic plaque radiation therapy for choroidal melanoma: 400 treated patients. Ophthalmology116, 790–796 (2009).
   PubMed Web of Science ®Google Scholar
• Mashayekhi A, Tuncer S, Shields C, Shields J. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch’s membrane rupture. Ophthalmology117(5), 1013–1023 (2010).
   PubMedGoogle Scholar
• Shields C, Materin M, Teixeira L, Mashayekhi A, Ganguly A, Shields J. Small choroidal melanoma with chromosome 3 monosomy on fine needle aspiration biopsy. Ophthalmology114, 1919–1924 (2007).
   PubMedGoogle Scholar
• Sobrin L, Schiffman J, Markoe A, Murray T. Outcomes of iodine 125 plaque radiotherapy after initial observation of suspected small choroidal melanomas: a pilot study. Ophthalmology112, 1777–1783 (2005).
   PubMed Web of Science ®Google Scholar
• Sen J, Groenewald C, Hiscott P, Smith P, Damato B. Transretinal choroidal tumor biopsy with 25-gauge vitrector. Ophthalmology113, 1028–1031 (2006).
   PubMedGoogle Scholar
• Augsburger J, Correa Z, Shaikh A. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Trans. Am. Ophthalmol. Soc.106, 128–137 (2008).
   PubMedGoogle Scholar
• Bellmann C, Lumbroso-Le Rouic L, Levy C et al. Uveal melanoma: management and outcome of patients with extra-ocular spread. Br. J. Ophthalmol.94, 569–574 (2010).
   PubMed Web of Science ®Google Scholar
• Cryan L, Paraoan L, Hiscott P et al. Expression of COX-2 and prognostic outcome in uveal melanoma. Curr. Eye Res.33(2), 177–184 (2008).
   PubMed Web of Science ®Google Scholar
• Kaiserman I, Rosner M, Pe’er J. Forecasting the prognosis of choroidal melanoma with an artificial neural network. Ophthalmology112, 1608–1611 (2005).
   PubMedGoogle Scholar
• Damato B, Eleuteri A, Fisher A, Coupland S, Taktak A. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Ophthalmology115, 1598–1607 (2008).
   PubMed Web of Science ®Google Scholar